- Home
- HURA vs ORMP Comparison
HURA vs ORMP Comparison
Compare HURA & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HURA | ORMP |
|---|---|---|
| Founded | 2009 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.5M | 170.3M |
| IPO Year | 2010 | 2010 |
Fundamental Metrics
Financial Performance| Metric | HURA | ORMP |
|---|---|---|
| Price | $2.18 | $4.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | 162.8K | ★ 199.5K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | 47.93 | ★ 412.50 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.71 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $0.41 | $2.09 |
| 52 Week High | $3.43 | $5.47 |
Technical Indicators
Market Signals| Indicator | HURA | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 53.15 | 50.12 |
| Support Level | $2.04 | $3.91 |
| Resistance Level | $2.24 | $5.10 |
| Average True Range (ATR) | 0.09 | 0.18 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 87.50 | 29.51 |
Price Performance
Historical ComparisonAbout HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.